4.7 Article

Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infants

Journal

JOURNAL OF INFECTION
Volume 72, Issue 3, Pages 283-294

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.jinf.2015.12.014

Keywords

Neonatal infection; Group B Streptococcus; Vaccines; Immunity

Funding

  1. Wellcome Trust Clinical Research Fellowship [WT104482MA]
  2. Thrasher Research Fund [BK: 12250]
  3. UK MRC [MC_UP_A900/1122, MC_UP_A900/115]
  4. UK Medical Research Council (MRC)
  5. Department for International Development (DFID) under the MRC/DFID Concordat arrangement
  6. MRC [MC_UP_A900_1122] Funding Source: UKRI
  7. Medical Research Council [MC_UP_A900_1122] Funding Source: researchfish

Ask authors/readers for more resources

Objectives: To determine risk factors for GBS colonisation in Gambian mothers and in their infants from birth to day 60-89 of age. Methods: Swabs and breastmilk from mothers/infant pairs were collected and cultured on selective agar. Negative samples were analysed for GBS DNA via real-time PCR. Positive isolates were serotyped using multiplex PCR and gel-agarose electrophoresis. Results: Seven hundred and fifty women/infant pairs were recruited. 253 women (33.7%) were GBS-colonised at delivery. The predominant serotypes were: V (55%), II (16%), III (10%), Ia (8%) and Ib (8%). 186 infants were colonised (24.8%) at birth, 181 (24.1%) at 6 days and 96 at day 60-89 (14%). Infants born before 34 weeks of gestation and to women with rectovaginal and breastmilk colonisation at delivery had increased odds of GBS colonisation at birth. Season of birth was associated with increased odds of persistent infant GBS colonisation (dry season vs. wet season AOR 2.9; 95% CI 1.6-5.2). Conclusion: GBS colonisation is common in Gambian women at delivery and in their infants to day 60-89 and is dominated by serotype V. In addition to maternal colonisation, breastmilk and season of birth are important risk factors for infant GBS colonisation. Crown Copyright (C) 2015 Published by Elsevier Ltd on behalf of The British Infection Association.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available